Sultania Cardiovascular Sciences

Sultania Cardiovascular Sciences This page is,dedicated for cardiovascular knowledge

   .In 1953, Swedish cardiologist Inge Edler and physicist Carl Hellmuth Hertz recorded the first echocardiogram — the f...
31/01/2026

.
In 1953, Swedish cardiologist Inge Edler and physicist Carl Hellmuth Hertz recorded the first echocardiogram — the first ultrasound‑based moving recording of the heart — using an industrial ultrasonic reflectoscope, marking the birth of clinical echocardiography.

  Decade of Cardiology (1895–1905)  Big inventions●1895 – X-rays: Roentgen → First non-invasive visualization of the hea...
31/01/2026

Decade of Cardiology (1895–1905)

Big inventions

●1895 – X-rays: Roentgen → First non-invasive visualization of the heart.He got Noble Prize in Physics
●1896–1905 – Blood Pressure: Riva-Rocci & Korotkoff → Accurate BP measurement
●1903 – ECG: Willem Einthoven → Recording of cardiac electrical activity.He got noble prize in physiology

Significance:
This decade transformed cardiology into a measurement-based science, marking the birth of modern cardiology.

  line of Stethoscope ●Pre-1816Direct ear auscultation●1816  invents the monaural stethoscope●1825Stokes publishes on st...
31/01/2026

line of Stethoscope
●Pre-1816
Direct ear auscultation
●1816
invents the monaural stethoscope
●1825
Stokes publishes on stethoscope use
●1830
Trier publishes textbook in Denmark
●1851–1852
Binaural stethoscope developed
●1961–1963
Littmann modern acoustic stethoscope
●2000s onward
Electronic/digital stethoscopes emerged

31/01/2026

Celebrating my 8th year on Facebook. Thank you for your continuing support. I could never have made it without you. 🙏🤗🎉

  Harvey (1578–1657), in De Motu Cordis (1628), proved that the heart pumps blood in a continuous loop, overturning cent...
29/01/2026

Harvey (1578–1657), in De Motu Cordis (1628), proved that the heart pumps blood in a continuous loop, overturning centuries of Galen’s ideas. The birth of modern cardiovascular science!

Must read this synopsis of article & think of it to include in our practiceProphylactic Adenosine in SVG Interventions.....
13/01/2026

Must read this synopsis of article & think of it to include in our practice

Prophylactic Adenosine in SVG Interventions...
Step 1 ..See Global data
Slow Flow/No flow ..29% in ACS setting & 15 % in Stable settings of SVG intervention

Step 2..Only recommended prophylactic measure is use of EPD ,but know it is costly ,not available every where,need skills

Step 3..Our poulation
N=171 (142 ACS ,29 Stable setting)
we used liberous dose of adenosine(200-400ug ) as bolus just 30 seconds before balloon /stent inflation
Step 4..See results,

Slow flow ...4.8%
No reflow 1.2
Only in pts with base line TIMI flow 3 % ,& 0% in baseline TIMI flow >3%.

2ndly it proved very safe to give no significant brady or hypotention

https://www.sciencedirect.com/science/article/pii/S2772930325016084

  Classification of
12/01/2026

Classification of

  prevention is the prevention of the emergence or development of risk factors in a population by controlling the social...
12/01/2026

prevention is the prevention of the emergence or development of risk factors in a population by controlling the social, economic, and environmental conditions that lead to disease.

 -White sign (S1Q3T3)Non Sensitive but specific sign of acute pulmonary embolism
11/01/2026

-White sign (S1Q3T3)
Non Sensitive but specific sign of acute pulmonary embolism

  :If DAPT is, required during pregnancy due to PCI ,then Clopidogral is Class I to give in addition to aspirin for stan...
10/01/2026

:
If DAPT is, required during pregnancy due to PCI ,then Clopidogral is Class I to give in addition to aspirin for standard duration.
& Heart Disease

 •Mechanism: Reversible COX-1 inhibitor leading to decrease  thromboxane A2 &  inhibits platelet aggregation•Dose: 100 m...
10/01/2026


•Mechanism: Reversible COX-1 inhibitor leading to decrease thromboxane A2 & inhibits platelet aggregation
•Dose: 100 mg twice daily
•Use: Alternative to aspirin in DAPT after drug-eluting stent, esp. in high bleeding risk or aspirin intolerance or Allergy
•Trial: OPTION Trial – non-inferior to aspirin + clopidogrel, with lower bleeding risk

09/01/2026

Address

CPEIC Multan
Multan
66000

Website

Alerts

Be the first to know and let us send you an email when Sultania Cardiovascular Sciences posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram